NewsRamp is a PR & Newswire Technology platform that enhances press release distribution by adapting content to align with how and where audiences consume information. Recognizing that most internet activity occurs outside of search, NewsRamp improves content discovery by programmatically curating press releases into multiple unique formats—news articles, blog posts, persona-based TLDRs, videos, audio, and Zero-Click content—and distributing this content through a network of news sites, blogs, forums, podcasts, video platforms, newsletters, and social media.
FAQ: HeartBeam's Recognition as a Global Innovator in Portable ECG Technology
TL;DR
HeartBeam's second-place global ranking in ECG innovation provides investors with a competitive edge in the rapidly growing remote cardiac diagnostics market.
HeartBeam's proprietary system captures heart signals in three noncoplanar dimensions and synthesizes them into a 12-lead ECG using advanced intellectual property.
HeartBeam's portable ECG technology enables better cardiac care access outside medical facilities, improving heart health monitoring for patients worldwide.
HeartBeam ranked second globally among 243 companies for its innovative 3D ECG technology that transforms portable cardiac diagnostics.
Found this article helpful?
Share it with your network and spread the knowledge!
HeartBeam is a medical-technology company developing advanced electrocardiogram solutions for remote cardiac care that was recognized as a Global IP and Technology Leader in Portable Cardiac Diagnostics by PatentVest's 'Total Cardiac Intelligence' report, ranking second worldwide in 12-lead ECG innovation among 243 companies analyzed.
The ranking underscores the rapid maturation of HeartBeam's proprietary synthesis-ECG system and highlights the company's growing influence in the next generation of cardiac monitoring technology, positioning it as a major innovator behind only GE Healthcare in 12-lead ECG innovation.
HeartBeam's system captures the heart's electrical signals in three noncoplanar dimensions and synthesizes them into a 12-lead ECG, creating the first-ever cable-free device capable of collecting ECG signals in 3D from three non-coplanar directions.
The HeartBeam System is a portable non-invasive recorder intended to record, store, and transfer a patient's 3-Lead ECG acquired from 5 electrodes, intended for use by adult patients in either clinical settings or at home for manual interpretation of non-life-threatening arrhythmias by healthcare professionals.
HeartBeam's 3D ECG technology received FDA clearance for arrhythmia assessment in December 2024, while the 12-Lead ECG synthesis software is currently under FDA review.
HeartBeam's intellectual-property foundation is cited as a major reason for its high placement in the innovation ranking, with the company holding over 20 issued patents related to technology enablement.
The device is intended to be used by adult patients in either a clinical setting or at home, making it suitable for remote cardiac monitoring outside of traditional medical facilities.
HeartBeam's platform technology is designed for portable devices that can be used wherever the patient is to deliver actionable heart intelligence, allowing physicians to identify cardiac health trends and acute conditions outside of medical facilities.
The device itself does not conduct cardiac analysis but can be used with an ECG Viewer software system for manual interpretation of non-life-threatening arrhythmias by a physician or healthcare professional.
For full safety information, see the full Instructions for Use or Clinician Portal Manual.
Curated from NewMediaWire
